Novavax (NVAX) closed at $7.91 in the latest trading session, marking a -0.57% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.08%. On the other hand, the Dow ...

Vaccine Research Market Governments and private entities are heavily investing in vaccine research and development.US, NY, UNITED STA ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

BMC, a TMR-based vaccine manufacturer, has cancelled a contract with American biotech firm Novavax almost five years to the ...